2016
DOI: 10.1038/srep24029
|View full text |Cite
|
Sign up to set email alerts
|

Combined approaches of EPR and NMR illustrate only one transmembrane helix in the human IFITM3

Abstract: Interferon-inducible transmembrane protein IFITM3 was known to restrict the entry of a wide spectrum of viruses to the cytosol of the host. The mechanism used by the protein to restrict viral entry is unclear given the unavailability of the membrane topology and structures of the IFITM family proteins. Systematic site-directed spin labeling (SDSL) and electron paramagnetic resonance (EPR) studies of IFITM3 in detergent micelles identified a single, long transmembrane helix in the C-terminus and an intramembran… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

11
74
3

Year Published

2016
2016
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 50 publications
(88 citation statements)
references
References 34 publications
11
74
3
Order By: Relevance
“…To confirm these observations, cells were stained either intact, or following permeabilization, and analyzed by flow cytometry to determine levels of each IFITM protein at the cell surface. Antibodies against the C‐terminal HA‐tag were used as we, and others, have shown the IFITM proteins to have a type‐II transmembrane topology with the C‐terminal domain facing the extracellular space . The mean fluorescence intensity (MFI) of labeled OS‐IFITM1‐HA, P1‐IFITM1‐HA and P2‐IFITM3‐Y20A‐HA was essentially equivalent between intact and permeabilized cells, suggesting the HA‐tag is accessible at the cell surface (Figure B).…”
Section: Resultsmentioning
confidence: 95%
“…To confirm these observations, cells were stained either intact, or following permeabilization, and analyzed by flow cytometry to determine levels of each IFITM protein at the cell surface. Antibodies against the C‐terminal HA‐tag were used as we, and others, have shown the IFITM proteins to have a type‐II transmembrane topology with the C‐terminal domain facing the extracellular space . The mean fluorescence intensity (MFI) of labeled OS‐IFITM1‐HA, P1‐IFITM1‐HA and P2‐IFITM3‐Y20A‐HA was essentially equivalent between intact and permeabilized cells, suggesting the HA‐tag is accessible at the cell surface (Figure B).…”
Section: Resultsmentioning
confidence: 95%
“…IFITM3 comprises two S-fatty-acylation sites (C71 and C72) in proximity of a intramembrane domain, which were identified by our direct method (Figure 5B), and another site adjacent to a transmembrane domain (C105). 10,48 Our recent analysis of IFITM3 S-fatty-acylation by acyl-PEG exchange (APE) and alk-16 labeling revealed that C72A was the major site of S-fatty-acylation. 30 Since trypsin digest of IFITM3 results in large hydrophobic peptides (>29 amino acids), it appeared advantageous to digest IFITM3 with chymotrypsin, yielding 8–10 amino acid long peptides (SI Figure 18).…”
Section: Resultsmentioning
confidence: 99%
“…10,48 (B) MS/MS spectra of IFITM3 C71-ca, C72-ca was obtained following chymotrypsin digest. (C) MS/MS spectra of IFITM3 modified peptide showing S-palmitoylation on C72.…”
Section: Figurementioning
confidence: 99%
“…IFITMs have no catalytic subunit but share similar domain architectures consisting of a short N-terminal domain, two antiparallel domains, a conserved intracellular loop, and a hydrophobic C-terminal domain (4,5). The topology of IFITM3 has been clarified by electron paramagnetic and nuclear magnetic resonance analyses; the N-terminal domain is located inside the cell, whereas the antiparallel domains reside as intramembrane ␣-helices, followed by the transmembrane C-terminal domain (6). Although IFITM1, -2, and -3 all have reported antiviral activity, IFITM3 exhibits the greatest protection against the broadest range of viruses, including influenza A virus (IAV), flaviviruses (dengue, West Nile [WNV], and Japanese encephalitis viruses), hepaciviruses (hepatitis C virus), filoviruses (Ebola and Marburg viruses), bunyaviruses (Rift Valley fever and La Crosse viruses), rhabdoviruses (vesicular stomatitis virus), coronaviruses (severe acute respiratory syndrome coronavirus [SARS-CoV]), paramyxoviruses (respiratory syncytial virus [RSV]), and reoviruses (7)(8)(9)(10)(11)(12)(13)(14)(15)(16)(17).…”
mentioning
confidence: 99%